SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs informs about voting results and scrutinizer report

03 Aug 2023 Evaluate

In compliance with Reg 44 (3) of SEBI (LODR) Regulations, 2015; Lyka Labs has informed that it enclosed Consolidated results of e-voting of the AGM in the prescribed format along with the Scrutinizer Reports. Considering the votes cast in favour of the resolutions, all the resolutions were carried (passed) with requisite majority.

The above information is a part of company’s filings submitted to BSE.


Lyka Labs Share Price

58.16 0.56 (0.97%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×